274 related articles for article (PubMed ID: 29046434)
1. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia.
Ng AWT; Poon SL; Huang MN; Lim JQ; Boot A; Yu W; Suzuki Y; Thangaraju S; Ng CCY; Tan P; Pang ST; Huang HY; Yu MC; Lee PH; Hsieh SY; Chang AY; Teh BT; Rozen SG
Sci Transl Med; 2017 Oct; 9(412):. PubMed ID: 29046434
[TBL] [Abstract][Full Text] [Related]
2. Aristolochic Acid in the Etiology of Renal Cell Carcinoma.
Hoang ML; Chen CH; Chen PC; Roberts NJ; Dickman KG; Yun BH; Turesky RJ; Pu YS; Vogelstein B; Papadopoulos N; Grollman AP; Kinzler KW; Rosenquist TA
Cancer Epidemiol Biomarkers Prev; 2016 Dec; 25(12):1600-1608. PubMed ID: 27555084
[TBL] [Abstract][Full Text] [Related]
3. Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes.
Chen CH; Dickman KG; Huang CY; Moriya M; Shun CT; Tai HC; Huang KH; Wang SM; Lee YJ; Grollman AP; Pu YS
Int J Cancer; 2013 Jul; 133(1):14-20. PubMed ID: 23292929
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide mutational signatures of aristolochic acid and its application as a screening tool.
Poon SL; Pang ST; McPherson JR; Yu W; Huang KK; Guan P; Weng WH; Siew EY; Liu Y; Heng HL; Chong SC; Gan A; Tay ST; Lim WK; Cutcutache I; Huang D; Ler LD; Nairismägi ML; Lee MH; Chang YH; Yu KJ; Chan-On W; Li BK; Yuan YF; Qian CN; Ng KF; Wu CF; Hsu CL; Bunte RM; Stratton MR; Futreal PA; Sung WK; Chuang CK; Ong CK; Rozen SG; Tan P; Teh BT
Sci Transl Med; 2013 Aug; 5(197):197ra101. PubMed ID: 23926199
[TBL] [Abstract][Full Text] [Related]
5. Toward clinical understanding of aristolochic acid upper-tract urothelial carcinoma.
Boot A; Jiang N; Rozen SG
Theranostics; 2020; 10(12):5578-5580. PubMed ID: 32373232
[TBL] [Abstract][Full Text] [Related]
6. [Study and opinion on toxicity of aristolochic acid].
Gao Y; Xiao XH; Zhu XX; Liang AH; Zhang BL
Zhongguo Zhong Yao Za Zhi; 2017 Nov; 42(21):4049-4053. PubMed ID: 29271138
[TBL] [Abstract][Full Text] [Related]
7. Mutational Processes in Hepatocellular Carcinoma: The Story of Aristolochic Acid.
Nault JC; Letouzé E
Semin Liver Dis; 2019 Jul; 39(3):334-340. PubMed ID: 31041788
[TBL] [Abstract][Full Text] [Related]
8. The Mutational Features of Aristolochic Acid-Induced Mouse and Human Liver Cancers.
Lu ZN; Luo Q; Zhao LN; Shi Y; Wang N; Wang L; Han ZG
Hepatology; 2020 Mar; 71(3):929-942. PubMed ID: 31692012
[TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid.
Jelaković B; Castells X; Tomić K; Ardin M; Karanović S; Zavadil J
Int J Cancer; 2015 Jun; 136(12):2967-72. PubMed ID: 25403517
[TBL] [Abstract][Full Text] [Related]
10. Mutation signatures implicate aristolochic acid in bladder cancer development.
Poon SL; Huang MN; Choo Y; McPherson JR; Yu W; Heng HL; Gan A; Myint SS; Siew EY; Ler LD; Ng LG; Weng WH; Chuang CK; Yuen JS; Pang ST; Tan P; Teh BT; Rozen SG
Genome Med; 2015; 7(1):38. PubMed ID: 26015808
[TBL] [Abstract][Full Text] [Related]
11. Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease.
Grollman AP
Environ Mol Mutagen; 2013 Jan; 54(1):1-7. PubMed ID: 23238808
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of the possible carcinogenic role of the aristolochic acid.
Bara T; Gurzu S; Sugimura H; Bara T; Beleaua MA; Jung I
Rom J Morphol Embryol; 2017; 58(1):41-44. PubMed ID: 28523296
[TBL] [Abstract][Full Text] [Related]
13. Carcinogens that induce the A:T > T:A nucleotide substitutions in the genome.
Zhou G; Zhao X
Front Med; 2018 Apr; 12(2):236-238. PubMed ID: 29209916
[TBL] [Abstract][Full Text] [Related]
14. Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing.
Hoang ML; Chen CH; Sidorenko VS; He J; Dickman KG; Yun BH; Moriya M; Niknafs N; Douville C; Karchin R; Turesky RJ; Pu YS; Vogelstein B; Papadopoulos N; Grollman AP; Kinzler KW; Rosenquist TA
Sci Transl Med; 2013 Aug; 5(197):197ra102. PubMed ID: 23926200
[TBL] [Abstract][Full Text] [Related]
15. Mutational signature of aristolochic acid: Clue to the recognition of a global disease.
Rosenquist TA; Grollman AP
DNA Repair (Amst); 2016 Aug; 44():205-211. PubMed ID: 27237586
[TBL] [Abstract][Full Text] [Related]
16. Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid.
Castells X; Karanović S; Ardin M; Tomić K; Xylinas E; Durand G; Villar S; Forey N; Le Calvez-Kelm F; Voegele C; Karlović K; Mišić M; Dittrich D; Dolgalev I; McKay J; Shariat SF; Sidorenko VS; Fernandes A; Heguy A; Dickman KG; Olivier M; Grollman AP; Jelaković B; Zavadil J
Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1873-81. PubMed ID: 26383547
[TBL] [Abstract][Full Text] [Related]
17. Aristolochic acids detected in some raw Chinese medicinal herbs and manufactured herbal products--a consequence of inappropriate nomenclature and imprecise labelling?
Cheung TP; Xue C; Leung K; Chan K; Li CG
Clin Toxicol (Phila); 2006; 44(4):371-8. PubMed ID: 16809138
[TBL] [Abstract][Full Text] [Related]
18. Recognition of the toxicity of aristolochic acid.
Zhang HM; Zhao XH; Sun ZH; Li GC; Liu GC; Sun LR; Hou JQ; Zhou W
J Clin Pharm Ther; 2019 Apr; 44(2):157-162. PubMed ID: 30548302
[TBL] [Abstract][Full Text] [Related]
19. Is aristolochic acid nephropathy a widespread problem in developing countries? A case study of Aristolochia indica L. in Bangladesh using an ethnobotanical-phytochemical approach.
Michl J; Jennings HM; Kite GC; Ingrouille MJ; Simmonds MS; Heinrich M
J Ethnopharmacol; 2013 Aug; 149(1):235-44. PubMed ID: 23806867
[TBL] [Abstract][Full Text] [Related]
20. Aristolochic acid-associated cancers: a public health risk in need of global action.
Das S; Thakur S; Korenjak M; Sidorenko VS; Chung FF; Zavadil J
Nat Rev Cancer; 2022 Oct; 22(10):576-591. PubMed ID: 35854147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]